Search research articles
Contact Us
Filters
Showing results (71-80 of 161) with videos related to
Page
of 17
Sort By:
Diabetologia
|
June 7, 2015
Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice
Varun Pathak, Srividya Vasu, Victor A Gault, et al.
Molecular and Cellular Endocrinology
|
July 29, 2016
Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
Dawood Khan, Srividya Vasu, R Charlotte Moffett, et al.
Biological Chemistry
|
October 22, 2008
Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes
Nigel Irwin, Paula L McClean, Steven Patterson, et al.
Peptides
|
September 3, 2023
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice
Ananyaa Sridhar, Dawood Khan, Peter R Flatt, et al.
Biochemical Pharmacology
|
March 31, 2022
GABA and insulin but not nicotinamide augment α- to β-cell transdifferentiation in insulin-deficient diabetic mice
Dipak Sarnobat, R Charlotte Moffett, Peter R Flatt, et al.
Peptides
|
February 24, 2022
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A Lafferty, Peter R Flatt, et al.
European Journal of Pharmacology
|
November 6, 2010
Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice
David W Porter, Nigel Irwin, Peter R Flatt, et al.
Biochimie
|
January 25, 2019
Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival
Shruti Mohan, R Charlotte Moffett, Keith G Thomas, et al.
Biological Chemistry
|
January 30, 2008
Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity
Ashley Taylor, Nigel Irwin, Aine M McKillop, et al.
Diabetes, Obesity & Metabolism
|
October 16, 2023
Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Neil Tanday, Andrei I Tarasov, R Charlotte Moffett, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 161) with videos related to
Sort By:
Page
of 17
Diabetologia
|
June 7, 2015
Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice
Varun Pathak, Srividya Vasu, Victor A Gault, et al.
Molecular and Cellular Endocrinology
|
July 29, 2016
Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
Dawood Khan, Srividya Vasu, R Charlotte Moffett, et al.
Biological Chemistry
|
October 22, 2008
Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes
Nigel Irwin, Paula L McClean, Steven Patterson, et al.
Peptides
|
September 3, 2023
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice
Ananyaa Sridhar, Dawood Khan, Peter R Flatt, et al.
Biochemical Pharmacology
|
March 31, 2022
GABA and insulin but not nicotinamide augment α- to β-cell transdifferentiation in insulin-deficient diabetic mice
Dipak Sarnobat, R Charlotte Moffett, Peter R Flatt, et al.
Peptides
|
February 24, 2022
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A Lafferty, Peter R Flatt, et al.
European Journal of Pharmacology
|
November 6, 2010
Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice
David W Porter, Nigel Irwin, Peter R Flatt, et al.
Biochimie
|
January 25, 2019
Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival
Shruti Mohan, R Charlotte Moffett, Keith G Thomas, et al.
Biological Chemistry
|
January 30, 2008
Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity
Ashley Taylor, Nigel Irwin, Aine M McKillop, et al.
Diabetes, Obesity & Metabolism
|
October 16, 2023
Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Neil Tanday, Andrei I Tarasov, R Charlotte Moffett, et al.
Page
of 17